ST. PAUL, Minn.--(BUSINESS WIRE)--June 14, 2006--St. Jude Medical, Inc. (NYSE:STJ - News) today announced European CE Mark approval for two new electrophysiology (EP) products - the Therapy(TM) Cool Path(TM) all-braided ablation catheter and the IBI-1400-CV Internal Cardioversion system.